MDM2 and hematologic disorder: MDM2 is negatively regulated by specific microRNAs such as miR-1827 and miR-340 [34–36], and overexpression via multiple mechanisms is observed in various types of human malignancies, including sarcomas, gliomas, hematological malignancies, and breast cancer [34, 37].